Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of lorazepam oral liquid in paediatric ICU patients
2015-001043-37Phase 4Active
- Sponsor
- Erasmus MC
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of lorazepam in substance withdrawal, sponsored by Erasmus MC. Primary endpoint: Primary pharmacokinetic parameters of lorazepam. Started May 2015; status: active.
02
Drugs
lorazepam
03
Conditions
substance withdrawal
Beyond the preview
Go deeper on 2015-001043-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001043-37.